RedHill Biopharma Ltd. to Present at the Annual BioPharm America International Partnering Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TEL-AVIV, Israel, Sept. 11, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the 6th Annual BioPharm America International Partnering Conference, on Wednesday, September 18, 2013, at 3:00 p.m. EDT at the Westin Boston Waterfront Hotel in Boston, MA.

Help employers find you! Check out all the jobs and post your resume.

Back to news